Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Macrolides in Refractory Asthma
2007-006576-11Phase 2Terminated
- Sponsor
- University of Nottingham
- Start
- May 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of azithromycin in asthma, sponsored by University of Nottingham. Primary endpoint: Change from baseline in bronchial reactivity. Started May 2008; status: terminated.
02
Drugs
azithromycin
03
Conditions
asthma
Beyond the preview
Go deeper on 2007-006576-11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-006576-11.